Geha Mental Health Center
13
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
15.4%
2 terminated/withdrawn out of 13 trials
50.0%
-36.5% vs industry average
31%
4 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Adapted Visual Safety Plan for Autistic Youth (VSP-AY) to Address Self-harm, Suicidal Ideation, and Suicide Behaviors
Role: collaborator
Stratification and Treatment in Early Psychosis Study -ASSIST
Role: collaborator
Stratification and Treatment in Early Psychosis Study - ENHANCE
Role: collaborator
The Efficacy of "Mindtesion"is Measuring Attentional and the Startle Response Dysregulation in Children and Adolescents Suffering From Attention Deficit Disorder: With and Without Medication.
Role: lead
Effectiveness of a Cognitive Remediation Intervention Based on Virtual Reality for Promotion of Cognitive Functioning and Participation in Daily Life Among Persons With Affective Disorder
Role: lead
Evaluating Effectiveness of Dyadic Prolonged Exposure on 2-4 Years Old vs. Toddler-parent Focused Treatment
Role: collaborator
Optimizing the Resources of Psychotherapy as a Tool for Implementing the Mental Health Reform
Role: collaborator
Attention Bias Modification Treatment (ABMT) and Cognitive-Behavioral Group Therapy (CBGT) in Social Anxiety Disorder
Role: collaborator
Vitamin D for Schizophrenia
Role: lead
Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients
Role: lead
Comparative Study of SR Bupropion for Adolescent Smoking Cessation
Role: lead
Methylphenidate in ADHD With Trichotillomania
Role: lead
Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study
Role: lead
All 13 trials loaded